Progestins and Antiprogestins in Clinical Practice
This review covers the structure and action of progesterone receptors, physiological effects of progestins in the brain and breast, pharmacology of various synthetic progestins, and their clinical applications in contraception, menopause, breast diseases, and other indications, alongside antiprogestins and pharmacokinetic considerations.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (10)
- Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial 2013
- The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study 2012
- The use of newer progestins for contraception 2010
- Reprint of Classification and pharmacology of progestins 2008
- Reprint of Pharmacological profile of progestins 2008
- Pharmacology of different progestogens: the special case of drospirenone 2005
- Pharmacological profile of progestins 2004
- Newer progestogens 2003
- All progestins are not created equal 2003
- Progesterone receptor modulators and progesterone antagonists in women's health 2000
Source provenance
- openalex
- last seen: 2026-05-11T04:45:27.910651+00:00